The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Peter J. Fitzgerald
Showing 1-13 of 13 articles
Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up
Nakatani S,
Sotomi Y,
Ishibashi Y,
Grundeken M.J,
Tateishi H,
Tenekecioglu E,
Zeng Y,
Suwannasom P,
Regar E,
Radu M,
Räber L,
Bezerra H,
Costa M,
Fitzgerald P,
Prati F,
Costa R,
Dijkstra J,
Kimura T,
Kozuma K,
Tanabe K,
Akasaka T,
Di Mario C,
Serruys P,
Onuma Y
December 20, 2016 | 10.4244/EIJY15M10_03
Comparing the vascular response in implantation of self-expanding, bare metal nitinol stents or paclitaxel-eluting nitinol stents in superficial femoral artery lesions: a serial optical frequency domain imaging study
Miki K,
Fujii K,
Shibuya M,
Fukunaga M,
Imanaka T,
Tamaru H,
Nishimura M,
Horimatsu T,
Honda Y,
Fitzgerald P,
Masuyama T,
Ishihara M
December 20, 2016 | 10.4244/EIJ-D-15-00399
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
Iqbal J,
Verheye S,
Abizaid A,
Ormiston J,
De Vries T,
Morrison L,
Toyloy S,
Fitzgerald P,
Windecker S,
Serruys P
December 9, 2016 | 10.4244/EIJY15M10_04
Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography
Kitahara H,
Waseda K,
Yamada R,
Otagiri K,
Tanaka S,
Kobayashi Y,
Okada K,
Kume T,
Nakagawa K,
Teramoto T,
Ikeno F,
Yock P,
Fitzgerald P,
Honda Y
June 10, 2016 | 10.4244/EIJV12I2A32
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial
Sakata K,
Koo B,
Waseda K,
Nakatani D,
Yock P,
Whitbourn R,
Worthley S,
Ormiston J,
Webster M,
Wilkins G,
Honda Y,
Meredith I,
Fitzgerald P
March 20, 2015 | 10.4244/EIJY14M08_16
Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial
Yamasaki M,
Tsujino I,
Lima-Filho M,
Ako J,
Shimohama T,
Hasegawa T,
Sakurai R,
Sudhir K,
Stone G,
Waseda K,
Honda Y,
Fitzgerald P
October 26, 2012 | 10.4244/EIJV8I6A112
First-in-human experience with the Medtronic Bifurcation Stent System
Meredith I,
Worthley S,
Whitbourn R,
Webster M,
Fitzgerald P,
Ormiston J
October 28, 2011 | 10.4244/EIJV7I6A108
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study
Serruys P,
Garg S,
Abizaid A,
Ormiston J,
Windecker S,
Verheye S,
Dubois C,
Stewart J,
Hauptmann K,
Schofer J,
Stangl K,
Witzenbichler B,
Wiemer M,
Barbato E,
de Vries T,
Drijver A-M,
Otake H,
Meredith L,
Toyloy S,
Fitzgerald P
June 30, 2010
EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions
Costa Júnior J,
Abizaid A,
Feres F,
Costa R,
Seixas A,
Maia F,
Abizaid An,
Tanajura L,
Staico R,
Siqueira D,
Meredith L,
Bhat V,
Yan J,
Ormiston J,
Sousa A,
Fitzgerald P,
Sousa J
May 13, 2008
Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results
Grube E,
Sievert H,
Hauptmann K-E,
Mueller R,
Gerckens U,
Buellesfeld L,
Ako J,
Shimohama T,
Costa M,
Fitzgerald P
May 13, 2008
The next-generation Endeavor™ Resolute™ stent: 4-month clinical and angiographic results from the Endeavor™ Resolute™ first-in-man trial
Meredith I,
Worthley S,
Whitbourn R,
Walters D,
Popma J,
Cutlip D,
Fitzgerald P
May 22, 2007
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesions
Costa R,
Eduardo Sousa J,
Abizaid A,
Chaves A,
Feres F,
Sousa A,
Musumeci G,
Mehran R,
Fitzgerald P,
Lansky AJ,
Leon MB,
Shiran A,
Halon D,
Lewis B,
Guagliumi G
November 20, 2006
First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial
Meredith I,
Ormiston J,
Whitbourn R,
Kay IP,
Muller DW,
Bonan R,
Popma J,
Cutlip D,
Fitzgerald P,
Prpic R,
Kuntz R
August 20, 2005
1
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023